Loading...
Domestic
Equity
Passive

RISE Healthcare (253280)

Update : 2026.09.22

NAV

11,967KRW

+51.74상승 (0.43%)

Market Price per share (KRW)

11,985KRW

+55상승 (0.46%)

※ t-1 last price

trading volume

229shares

AUM

KRW 7.1billion

RISE Healthcare (253280)

KEY POINT

Invest in domestic healthcare companies (medical equipment and services, bio, pharmaceutical)

KEY POINT

Invest in selected healthcare companies based on financial conditions among the top 500 companies by market capitalization of the KOSPI and KOSDAQ markets

Basic information

Download trading information

Update : 2026.09.22
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB RISE HealthCare ETF
(253280)
FnGuide HealthCare Index 2016.09.23 50,000 7,179,920,229
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 11,985
※ t-1 last price
11,966 229
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%) Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB RISE HealthCare ETF

(253280)
FnGuide HealthCare Index
Inception date Creation Unit
2016.09.23 50,000
AUM(0.1 billion) (KRW) Trustee
7,179,920,229 하나은행
Market Price per share (KRW) iNAV per share (KRW)
11,985
※ t-1 last price
11,966
Trading Volume (shares)
229
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%)
Distribution Frequency
Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Index is a market capitalization weighted index. The index selects stocks that satisfy financial and management soundness criteria out of the universe of stocks come under the medical sector in the MKF 500.

View detailed index information

TOP 10 Holdings

Update : 2026-09-22
Rank , Name, proportion table
Rank Name Weight (%)
1 Celltrion 12.31
2 SAMSUNG BIOLOGICS 12.18
3 Alteogen 10.78
4 Yuhan 6.08
5 HLB 5.50
6 HanmiPharm 4.64
7 SKBP 4.51
8 ABL Bio 3.32
9 SCD 3.27
10 LCB 3.15

proportion by sectors

*The proportion of investment stocks

Update : 2026.09.22
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2026-04-30 2026-05-06 25
2025-04-30 2025-05-07 20
2023-04-28 2023-05-03 16
2022-04-29 2022-05-03 60

Performance

performance

excel download

Update : 2026-09-22

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)
Since
inception
NAV -9.76 -12.51 -35.48 -22.08 10.34 -28.83 18.16
Benchmark Index -9.85 -12.62 -36.02 -22.52 9.98 -29.27 18.41
Outperformance 0.08 0.1 0.54 0.44 0.35 0.44 -0.25

daily Performance

excel download

date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW) Standard Tax Base Price (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2026.09.21 11,985 0.461상승 11,966.53 0.434상승 10,354.21
2026.09.18 11,930 -1.118하락 11,914.88 -1.707하락 10,354.35
2026.09.17 12,065 0.374상승 12,121.9 0.694상승 10,354.4
2026.09.16 12,020 -0.743하락 12,038.29 -0.908하락 10,354.44
2026.09.15 12,110 -0.411하락 12,148.69 -0.086하락 10,354.49
2026.09.14 12,160 -0.368하락 12,159.22 -0.790하락 10,354.53
2026.09.11 12,205 -1.493하락 12,256.24 -1.834하락 10,354.67
2026.09.10 12,390 -1.588하락 12,485.22 -1.168하락 10,354.72
2026.09.09 12,590 0.079상승 12,632.79 0.507상승 10,354.77
2026.09.08 12,580 -1.333하락 12,569.03 -1.751하락 10,354.81
2026.09.07 12,750 -1.009하락 12,793.05 -0.532하락 10,354.86
2026.09.04 12,880 1.457상승 12,861.64 1.037상승 10,355
2026.09.03 12,695 -2.195하락 12,729.51 -1.823하락 10,355.05
2026.09.02 12,980 -1.703하락 12,965.89 -1.847하락 10,355.09
2026.09.01 13,205 -1.307하락 13,209.89 -1.314하락 10,355.14
2026.08.31 13,380 -1.436하락 13,385.79 -1.798하락 10,355.19
2026.08.28 13,575 0.258상승 13,631.05 0.708상승 10,355.33
2026.08.27 13,540 -1.275하락 13,535.12 -1.119하락 10,355.38
2026.08.26 13,715 2.198상승 13,688.35 1.693상승 10,355.43
2026.08.25 13,420 -1.576하락 13,460.43 -1.910하락 10,355.47
2026.08.24 13,635 3.178상승 13,722.57 3.481상승 10,355.52

Holdings

Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares Weight(%) Market price (KRW)
1 Celltrion KR7068270008 406 12.31 73,648,400
2 SAMSUNG BIOLOGICS KR7207940008 52 12.18 72,904,000
3 Alteogen KR7196170005 253 10.78 64,515,000
4 Yuhan KR7000100008 481 6.08 36,363,600
5 HLB KR7028300002 1,030 5.5 32,908,500
6 HanmiPharm KR7128940004 55 4.64 27,775,000
7 SKBP KR7326030004 348 4.51 27,004,800
8 ABL Bio KR7298380007 368 3.32 19,835,200
9 SCD KR7000250001 121 3.27 19,565,700
10 LCB KR7141080002 230 3.15 18,837,000
11 PharmaResearch KR7214450009 58 3.15 18,850,000
12 SAMSUNG EPIS HOLDINGS KR70126Z0002 57 3.12 18,639,000
13 HANALL BIOPHARMA KR7009420001 306 2.39 14,320,800
14 ST Pharm KR7237690003 113 1.72 10,283,000
15 Hugel KR7145020004 46 1.58 9,476,000
16 SEEGENE KR7096530001 278 1.58 9,479,800
17 Hanmi Science KR7008930000 176 1.49 8,940,800
18 L&C BIO KR7290650001 180 1.38 8,244,000
19 SKBS KR7302440003 230 1.37 8,199,500
20 CLASSYS KR7214150005 232 1.2 7,180,400
21 Celltrionph KR7068760008 178 1.18 7,031,000
22 Lunit KR7328130000 608 1.06 6,353,600
23 원화예금 KRD010010001 6,200,315 1.04 6,200,315
24 GC Biopharma Corp. KR7006280002 48 1.01 6,033,600
25 Pharmicell KR7005690003 485 1 5,999,450
26 HK inno.N KR7195940002 123 0.79 4,753,950
27 CHONGKUNDANG KR7185750007 69 0.74 4,457,400
28 ORUM KR7475830006 161 0.73 4,395,300
29 DongKook Pharm KR7086450004 205 0.72 4,325,500
30 DAEWOONG PHARM KR7069620003 39 0.71 4,223,700
31 CHA Biotech KR7085660009 520 0.7 4,180,800
32 ShinpoongPharm KR7019170000 345 0.54 3,225,750
33 JWPHARMA KR7001060003 116 0.53 3,155,200
34 MedyTox KR7086900008 47 0.53 3,200,700
35 i-SENS KR7099190001 189 0.5 3,018,330
36 ILDONG PHARM KR7249420001 183 0.43 2,587,620
37 HLBPHARMA KR7047920004 321 0.41 2,455,650
38 EuBio KR7206650004 271 0.38 2,268,270
39 T&L KR7340570001 79 0.37 2,231,750
40 DENTIUM KR7145720009 57 0.36 2,131,800
41 CUREXO KR7060280005 253 0.34 2,013,880
42 WONTECH KR7336570007 374 0.31 1,838,210
43 GC Corp. KR7005250006 188 0.3 1,808,560
44 Binex KR7053030003 250 0.26 1,535,000
45 Huons Global KR7084110006 47 0.17 1,029,300
46 KLS KR7102940004 65 0.15 901,550
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.